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doi:10.1016/j.jtcvs.2003.12.032TObjectives: Endobronchial cryotherapy is an established recanalization method for
stenoses of the respiratory tract. However, previous applications of cryotherapy
have not been immediately effective, requiring a second clean-up procedure several
days later to finally obtain sufficient recanalization. In this study we demonstrate a
newly developed cryoprobe allowing recanalization of tumor stenoses during a
single intervention.
Methods: In this prospective study flexible bronchoscopy was used for cryoreca-
nalization of 60 patients with high-grade stenoses of the respiratory tract from
exophytic tumors. Tumor tissue was frozen on the tip of the probe and subsequently
removed from the surrounding respiratory tract tissue through retraction of the
probe. Procedures were carried out on sedated, spontaneously breathing, intubated
patients.
Results: Fifty (83%) of 60 patients were successfully or partially successfully
treated. Tumor bleeding occurred in 6 patients but was stopped with argon plasma
coagulator treatment in all patients not requiring rigid bronchoscopy.
Conclusion: Cryorecanalization with the newly developed cryoprobe permits effec-
tive, safe, and inexpensive therapy of endobronchial stenoses of the respiratory tract.
Currently, effective methods for the treatment of stenoses and clo-sures of the respiratory tract caused by exophytic tumors includelaser therapy with the Nd-YAG laser, mechanical recanalization(rigid bronchoscopic debulking), photodynamic therapy (PDT),and cryotherapy.1-3 The disadvantages of these methods include thenecessity of clean-up bronchoscopy to remove tumor necroses or
fibrin membranes (PDT and cryotherapy), the necessity of a primary procedure with
rigid bronchoscopy in total anesthesia (laser therapy and mechanical recanalization),
the lack of immediate effectiveness (cryotherapy and PDT), and high therapeutic
costs (PDT).1-3 In cryotherapy extreme cold is locally applied to induce tumor
necrosis by using a rigid or flexible probe. In a second bronchoscopy 5 to 10 days
after the first intervention, necrotic tumor tissue is removed.4 This strategy, although
effective, does not allow immediate recanalization of stenotic or occluded airways.
Thus we have examined the possibility of immediate exophytic tumor tissue
extraction after tumor freezing on the tip of a newly developed probe; this procedure
is referred to below as cryorecanalization. Initial experimental data from our group
showed that commercially available flexible cryoprobes used for cryotherapy are not
suitable for cryorecanalization because of their relatively low freezing power and
the lack of stability to traction of the gas channel in the probe tip. Because of these
limitations, only small pieces of tumor tissue could be extracted when these probes
were used; in addition, the gas channel was often dislocated from the probe tip by
means of traction, leading to defective probe function. These disadvantages could be
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alization. The present study sought to investigate the effec-
tiveness of cryorecanalization with such a newly developed
probe in patients with respiratory tract stenosis caused by
exophytic tumors.
Materials and Methods
Cryoprobe
The probe used for cryorecanalization was 78 cm in length and 2.3
mm in diameter. Differences from the probe used for cryotherapy
include stable attachment of the central gas channel in the probe
tip, resulting in greater stability to traction (50 N). In addition,
greater freezing power (Figure 1) was achieved by extending the
probe’s surface area. A hydrophilic coat facilitates the exact guid-
ance of the probe in the working channel of the bronchoscope. In
accordance with the Joule-Thompson principle, the probe tip is
cooled by means of gas decompression in the probe head.5 The
instrument we used (Erbokryo; ERBE Medizintechnik GmbH,
Tu¨bingen, Germany) uses nitrous oxide at an exit temperature of
89.5°C at the tip of the probe. The probe is a closed system that
can be resterilized and reused. Application for registration of the
probe has been made.
Patients
Indications for cryorecanalization were based on the following
findings:
● high-grade stenosis in the area of the central respiratory tracts
from exophytic tumors with clinical symptoms (dyspnea or
post-obstructive pneumonia) and
● stenosis-closure of a lobe or segment of a bronchus with
postobstructive pneumonia.
An airway narrowing that could not be passed with an Olympus
BF160P bronchoscope (outer diameter, 4.9 mm) despite pressure
Figure 1. Cryotherapy probe (back) and cryorecanalization probe
(front): formation of an ice ball after 1 minute of freezing in a
water bath. The freezing power of the cryorecanalization probe is
greater.exerted on the bronchoscope was defined as a high-grade stenosis.
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were not included. A thrombocyte count of greater than 100 G/L
and normal plasma clotting were prerequisites for the performance
of cryorecanalization. From January 2002 through May 2003, all
patients who presented at our department with these criteria were
included in the study. Cryorecanalization was performed in 60
patients aged 19 to 81 years. The causes and anatomic positions of
the endobronchial lesions in the group of patients are given in
Tables 1 and 2, respectively. Of 60 patients, 23 had complete
bronchial obstruction, whereas 37 had high-grade airway stenoses.
Of 23 patients, 17 had segmental or lobar atelectasis. All patients
were fully informed of possible complications and then gave their
written consent to treatment. The study was approved by the local
ethics committee.
Cryorecanalization
The cryorecanalization procedure is shown in Figure 2. After
inhalation of local anesthetic, patients were intubated with an
8.5-mm Bronchoflex tube (Ru¨sch GmbH). Oxygen (6-12 L/min)
was continuously insufflated through this tube. The procedure was
performed during sedation with propofol (200-2400 mg), with
spontaneous respiration. Patients were monitored by means of
continuous pulse oximetry, electrocardiography, and measurement
of blood pressure every 2 minutes. Eight patients temporarily
required a dopamine infusion for arterial hypotension during the
intervention.
Cryorecanalization was performed by means of flexible bron-
choscopy with an Olympus BF-1T160. The cryoprobe, guided
through the working channel of the bronchoscope, was placed
inside the tumor (1-2 cm). The probe tip was then cooled for 5 to
TABLE 2. Anatomic position of the stenoses and outcome
of cryorecanalization
Anatomic position of the
stenosis
No. of patients with
successful/partially
successful/unsuccessful
outcome
Trachea 5/1/0
Main bronchus 17/6/4
Upper lobe bronchus 4/1/2
Lower lobe bronchus 6/3/1
Middle lobe bronchus 1/0/1
Intermediate bronchus 4/2/2
TABLE 1. Cause of the stenoses
Cause of the stenosis of the respiratory tract
No. of
patients
Bronchial carcinoma 51
Metastases of a renal cell carcinoma 2
Metastases of carcinoma of the colon 2
Bronchial carcinoid 1
Benign granulations on tracheal stents 3
Malignant lymphoma 120 seconds. In most cases, freezing of the tumor tissue was
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assessment of the local extension of tissue freezing. Before the ice
front reached the healthy bronchial wall, frozen tumor tissue was
extracted from its surrounding tissue by pulling strongly on the
probe. Together with the bronchoscope, the tissue stuck to the tip
of the cryoprobe was pulled out of the respiratory tract. Frozen
tumor tissue was then released from the probe tip by thawing in a
water bath. The aim of the intervention was to repeat this proce-
dure until no relevant stenosis from exophytic portions of the
tumor remained. Mild bleeding around the site of removal of the
tumor was treated with topical application of adrenalin. More
intense bleeding was treated with argon plasma coagulation.
Evaluation of the Recanalization
Three different degrees of therapeutic success were distinguished:
● Successful: no residual stenosis detectable by means of en-
doscopy (reference segment, bronchial segment without
pathologic changes that lies immediately distal to the steno-
sis);
● Partially successful: residual stenosis evident in endoscopy
but stenosis passable with an Olympus BF-1T160 (optical
density, 6 mm) without pressure; and
● Unsuccessful: persistent nonpassable stenosis or closure.
Results
Cryorecanalization Allows Immediate Recanalization
of Respiratory Tract Stenoses
Sixty patients were treated. Complete recanalization was
achieved in 37 (61%) patients. Thirteen (22%) patients
exhibited residual stenoses that were easily passable with a
Figure 2. A, Exophytic tumor (colon carcinoma metasta
the cryorecanalization probe. C, Extraction of tumor tibronchoscope. Their treatment was rated as partially suc-
The Journal of Thoraciccessful. In 10 (17%) patients treatment was unsuccessful.
Tumor closures in these patients turned out to be too ex-
tended. No connection with the distal respiratory tract was
achieved, even though large quantities of tumor tissue were
extracted. The procedure lasted for between 9 and 81 min-
utes (41  16 minutes). On average, 13 (range, 3-31)
applications of the cryoprobe were required during one
intervention. Treatment success in our patients was inde-
pendent of the tumor cause and independent of the local-
ization of the stenosis.
Of 57 patients with malignant airway disease, 14 pre-
sented again with symptoms of recurrent airway obstruc-
tion. The time between the interventions ranged from 10 to
24 weeks (18  4 weeks; median time, 16 weeks). Thirty
patients died during follow-up after 36 weeks on average
(range, 6-67 weeks). Thirteen patients are still alive (mean
time of follow-up, 35 weeks; range, 24-71 weeks) without
any symptoms from airway stenosis. Follow-up of these
patients is still going on. However, all but 4 patients with
malignant airway stenoses received additional chemother-
apy, radiation therapy, or both.
Cryorecanalization is a Safe Procedure
None of the patients died during the procedure. Rigid bron-
choscopy to treat bleeding or other complications was not
needed in any of the patients. No patient had to be started on
mechanical ventilation after the procedure. After cryoreca-
nalization, 7 patients were subjected to intensive medical
in the right main bronchus. B, Freezing the tumor with
D, Right main bronchus after cryorecanalization.sis)monitoring for 12 hours because of high doses of propofol.
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stopped spontaneously within a couple of minutes. Six
patients had more intense bleeding (amount of blood loss,
100-300 mL) at the site of tumor adhesion after removal of
tumor tissue. In all of these patients, bleeding could be
controlled with suction with the flexible bronchoscope and
was stopped in all patients by using an argon plasma beamer
and flexible technology.
Discussion
Effectiveness of Cryorecanalization
In contrast to cryotherapy, cryorecanalization with a newly
developed probe is immediately effective in recanalization
of airway stenoses. This novel technique does not require
clean-up bronchoscopy several days after the cold treatment
to remove tumor necroses. The frozen tumor tissue sticking
to the cooled probe tip is extracted immediately during the
procedure. Therefore this method is also suitable for pa-
tients with acute symptoms caused by airway stenosis.
In 83% of our patients, cryorecanalization was partially
or completely successful. In those patients in whom no
recanalization could be achieved, tumor stenosis turned out
to be too extensive and thus did not allow connection with
the distal respiratory tract. However, high-grade airway
strictures should be considered for cryorecanalization only
when distal airway patency is preserved. As a suitable
method for better patient selection, we suggest virtual bron-
choscopy if available6 or bronchography. With these pre-
treatment procedures, probably the majority of unsuccessful
interventions in our study group could have been avoided.
Success rates of Nd-YAG laser therapy, which is the
most frequently used and best evaluated method for the
immediate management of endoluminal airway obstruc-
tions, range from 50% to 90% depending on the location of
the lesion.7 In our study cryorecanalization was successful
in 83% of the treated patients, with no difference between
tracheal or main stem bronchi and lobar bronchi lesions,
respectively.
Safety of Cryorecanalization
After extraction of frozen tumor tissue, endobronchial
bleeding requiring argon plasma beam coagulation occurred
in 6 of 60 patients. Cold causes vasoconstriction and cap-
illary microthromboses in the border area between frozen
and nonfrozen tissue.5 These effects likely contribute to the
low rate of bleeding complications with this method. Visual
control of the ice front is possible while the tissue is being
frozen, and this allows a relatively reliable assessment of the
depth of action. The rate of advance of the ice front de-
creases after longer times of freezing, providing an addi-
tional safeguard against accidental freezing of healthy tis-
sue. Accidental freezing of larger rings of cartilage is
recognizable because the probe cannot be removed from the
bronchus, even if it is very strongly pulled. The probe can
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end of the freezing process. The water content of cartilage
tissue is low, and this is probably the reason that cold causes
little cartilage necrosis in contrast to thermal energy.2 Fur-
thermore, in contrast to laser therapy, with its high thermal
energy release, cryorecanalization will be applicable in pa-
tients with coated airway stents and can be done at high
oxygen concentrations without increased risk.
Cryorecanalization works through conversion of fluid-
rich and vascularized tumor tissue close to the tip of the
probe into an adherent homogeneous ice ball and subse-
quent extraction of the frozen mass. The transition zone
from the tumor ice ball to the healthy airway wall, with its
unvascularized cartilage rings, represents an area of inho-
mogeneous ice formation.8 This zone is believed to be the
breaking area when traction is exerted on the probe, thus
preserving the healthy airway wall. Hence this mechanism
is likely to contribute to the safety of cryorecanalization.
Six patients exhibited more intense bleeding (amount of
blood loss, 300 mL in each patient). In all of these
patients, bleeding could be controlled with the suction of the
flexible bronchoscope and was stopped by argon plasma
beam coagulation. We assume, although we cannot prove,
the bleeding in these 6 patients would have stopped on its
own if we had waited longer before using the argon plasma
coagulator. Recent preliminary data from our group suggest
that the physiologic clotting system is indeed sufficient to
stop diffuse bleeding after tissue extraction. In conclusion,
we do not recommend argon plasma beam coagulation to be
included in the armamentarium required for cryorecanaliza-
tion, but we do recommend that rigid bronchoscopy be
made immediately available for potential complications
with this new method.
Conclusion
In contrast to PDT and cryotherapy, cryorecanalization is
immediately effective in the treatment of respiratory tract
stenoses caused by exophytic tumors. Also, cryorecanaliza-
tion does not require clean-up bronchoscopy. In addition,
our experience shows that cryorecanalization can be per-
formed with flexible technology. Moreover, cryorecanaliza-
tion is the most inexpensive of all recanalization methods
because the total therapeutic system can be purchased for
around 7000 €. The rate of complications with this method
is low, most likely because of the relative bioselectivity of
the action of low temperatures on vascularized tumor tissue
and the induction of vascular thromboses.8 On the basis of
our current experience with 60 patients, rigid bronchoscopy
is not necessary but should be kept immediately available
for potential complications with this new method. To our
knowledge, this is the first feasibility study with cryoreca-
nalization in patients with respiratory tract stenoses caused
by exophytic tumors. Still, future studies are needed to
y 2004
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methods.
In summary, cryorecanalization treatment with the newly
developed probe is a feasible technique and might offer
many advantages in the interventional therapy of stenosing
exophytic tumors of the respiratory tract: use of flexible
technology, immediate effectiveness, low risk of complica-
tions, and low costs in comparison with those of other
recanalization methods.
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